Style | Citing Format |
---|---|
MLA | Mirmosayyeb O, Bagherieh S, Shaygannejad V. "Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report." Human Vaccines and Immunotherapeutics, vol. 17, no. 11, 2021, pp. 4099-4101. |
APA | Mirmosayyeb O, Bagherieh S, Shaygannejad V (2021). Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report. Human Vaccines and Immunotherapeutics, 17(11), 4099-4101. |
Chicago | Mirmosayyeb O, Bagherieh S, Shaygannejad V. "Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report." Human Vaccines and Immunotherapeutics 17, no. 11 (2021): 4099-4101. |
Harvard | Mirmosayyeb O, Bagherieh S, Shaygannejad V (2021) 'Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report', Human Vaccines and Immunotherapeutics, 17(11), pp. 4099-4101. |
Vancouver | Mirmosayyeb O, Bagherieh S, Shaygannejad V. Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report. Human Vaccines and Immunotherapeutics. 2021;17(11):4099-4101. |
BibTex | @article{ author = {Mirmosayyeb O and Bagherieh S and Shaygannejad V}, title = {Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report}, journal = {Human Vaccines and Immunotherapeutics}, volume = {17}, number = {11}, pages = {4099-4101}, year = {2021} } |
RIS | TY - JOUR AU - Mirmosayyeb O AU - Bagherieh S AU - Shaygannejad V TI - Acute Cns Demyelination in a Subject With Cerebellar Ataxia Following the First Dose of Covid-19 Vaccine; a Case Report JO - Human Vaccines and Immunotherapeutics VL - 17 IS - 11 SP - 4099 EP - 4101 PY - 2021 ER - |